| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 ABHD17A NRCAM PODXL CAMK4 CAMK2B PCLO ADGRB3 ITGA8 CLSTN1 ERBIN MECP2 NEO1 IGF1R ABHD17B CADPS KCNJ8 PLCXD3 DGCR8 CDH2 | 1.25e-05 | 817 | 171 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic specialization | ABHD17A ATP7A NRCAM CAMK2B PCLO ADGRB3 ITGA8 EPB41L3 CLSTN1 ERBIN NEO1 ABHD17B DGCR8 DMD CDH2 | 1.74e-05 | 503 | 171 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | postsynaptic density | ABHD17A ATP7A NRCAM CAMK2B PCLO ADGRB3 ITGA8 EPB41L3 CLSTN1 NEO1 ABHD17B DGCR8 DMD CDH2 | 2.16e-05 | 451 | 171 | 14 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | ABHD17A ATP7A NRCAM CAMK2B PCLO ADGRB3 ITGA8 EPB41L3 CLSTN1 NEO1 ABHD17B DGCR8 DMD CDH2 | 3.98e-05 | 477 | 171 | 14 | GO:0032279 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ABHD17A ATP7A NRCAM CAMK2B PCLO ADGRB3 ITGA8 EPB41L3 CLSTN1 NEO1 ABHD17B DGCR8 DMD CDH2 | 1.06e-04 | 523 | 171 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | septin complex | 1.83e-04 | 14 | 171 | 3 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 1.83e-04 | 14 | 171 | 3 | GO:0005940 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.56e-04 | 201 | 171 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 2.79e-04 | 16 | 171 | 3 | GO:0032156 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.16e-04 | 157 | 171 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | syntrophin complex | 3.95e-04 | 4 | 171 | 2 | GO:0016013 | |
| GeneOntologyCellularComponent | lamellipodium | 6.29e-04 | 230 | 171 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | TRAMP complex | 6.55e-04 | 5 | 171 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | postsynapse | ABHD17A RPL27 ATP7A NRCAM CAMK4 CAMK2B PCLO ADGRB3 ITGA8 EPB41L3 CLSTN1 ERBIN MECP2 NEO1 IGF1R ABHD17B DGCR8 DMD CDH2 | 6.91e-04 | 1018 | 171 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 7.83e-04 | 88 | 171 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | cell leading edge | ATP7A PODXL ITGA8 EPB41L3 PTPN13 AVIL SYNE2 SNTG1 HAX1 DMD CDH2 PLCE1 | 8.72e-04 | 500 | 171 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 9.77e-04 | 6 | 171 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | sarcolemma | 9.82e-04 | 190 | 171 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.05e-03 | 94 | 171 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | postsynaptic endosome | 1.22e-03 | 26 | 171 | 3 | GO:0098845 | |
| GeneOntologyCellularComponent | Z disc | 1.54e-03 | 151 | 171 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | intercalated disc | 2.34e-03 | 68 | 171 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.47e-03 | 114 | 171 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 2.47e-03 | 114 | 171 | 5 | GO:0005798 | |
| GeneOntologyCellularComponent | I band | 2.48e-03 | 166 | 171 | 6 | GO:0031674 | |
| Domain | Protocadherin | 7.44e-06 | 5 | 171 | 3 | PF08374 | |
| Domain | Protocadherin | 7.44e-06 | 5 | 171 | 3 | IPR013585 | |
| Domain | Cadherin | 1.30e-05 | 118 | 171 | 8 | IPR002126 | |
| Domain | Ig_E-set | 4.81e-05 | 104 | 171 | 7 | IPR014756 | |
| Domain | CADHERIN_1 | 8.16e-05 | 113 | 171 | 7 | PS00232 | |
| Domain | Cadherin | 8.16e-05 | 113 | 171 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 8.62e-05 | 114 | 171 | 7 | PS50268 | |
| Domain | - | 8.62e-05 | 114 | 171 | 7 | 2.60.40.60 | |
| Domain | CA | 9.11e-05 | 115 | 171 | 7 | SM00112 | |
| Domain | Cadherin-like | 9.62e-05 | 116 | 171 | 7 | IPR015919 | |
| Domain | SPEC | 2.00e-04 | 32 | 171 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.00e-04 | 32 | 171 | 4 | IPR018159 | |
| Domain | G_SEPTIN_dom | 2.02e-04 | 13 | 171 | 3 | IPR030379 | |
| Domain | Septin | 2.02e-04 | 13 | 171 | 3 | PF00735 | |
| Domain | G_SEPTIN | 2.02e-04 | 13 | 171 | 3 | PS51719 | |
| Domain | Septin | 2.55e-04 | 14 | 171 | 3 | IPR016491 | |
| Domain | Cadherin_CS | 5.02e-04 | 109 | 171 | 6 | IPR020894 | |
| Pubmed | TENT4B ATP7A MAP7D3 PODXL CAMK4 BCLAF1 BEND3 COPG2 EPB41L3 ERBIN SH3BP4 EFTUD2 RIF1 IGF2BP3 NEO1 PTPN13 VPS13A ZNF638 MRPS9 ALB DGCR8 TOR1AIP1 PCDH9 GOLGA4 | 1.48e-12 | 777 | 175 | 24 | 35844135 | |
| Pubmed | RPL27 NRCAM MYCBP2 TEX2 CAMK4 BCLAF1 IARS1 CAMK2B SEPTIN9 PCLO U2SURP ADGRB3 EPB41L3 ERBIN FABP7 SEPTIN8 NEO1 CADPS KCTD10 RAB3GAP2 MRPS9 SMARCC2 EXOC1 HADHA HAX1 POLD3 SEPTIN10 CEP170B | 4.12e-12 | 1139 | 175 | 28 | 36417873 | |
| Pubmed | COL5A1 MYCBP2 U2SURP NSD1 ELP1 BEND3 COPG2 DDX51 EPB41L3 WDR43 DDX10 RIF1 IGF2BP3 SBF1 UTP15 SYNE2 ZNF638 SMARCC2 HADHA HSPA4 CPSF3 | 1.95e-11 | 653 | 175 | 21 | 22586326 | |
| Pubmed | RPL27 NRCAM HSPA4L BCLAF1 IARS1 CAMK2B SEPTIN9 PCLO ELP1 GTPBP1 EPB41L3 ERBIN MECP2 SLC4A1 SEPTIN8 PACS1 SBF1 CADPS KCTD10 ITSN2 MRPS9 SMARCC2 EXOC1 ALB HADHA HAX1 DMD CDH2 HSPA4 CEP170B | 3.32e-11 | 1431 | 175 | 30 | 37142655 | |
| Pubmed | RPL27 ARMC3 HSPA4L BCLAF1 CAMK2B PCLO U2SURP BEND3 NEB SMC2 EPB41L3 ERBIN MECP2 PRX RFTN1 UBB UBC TCHHL1 AVIL SYNE2 ITSN2 VPS13A PKHD1 MRPS9 SMARCC2 HADHA DMD SEPTIN10 DOP1A | 1.95e-10 | 1442 | 175 | 29 | 35575683 | |
| Pubmed | RPL27 ATP7A MYCBP2 HSPA4L TEX2 BCLAF1 ELP1 EPB41L3 ERBIN SH3BP4 DDX10 EFTUD2 ZNF512B NEO1 PTPN13 SBF1 SLC25A40 UTP15 RAB3GAP2 SYNE2 VPS13A MRPS9 HADHA HAX1 OGA TOR1AIP1 HSPA4 GOLGA4 NPAT | 3.97e-10 | 1487 | 175 | 29 | 33957083 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPL27 MAP7D3 BCLAF1 SEPTIN9 U2SURP NSD1 BEND3 COPG2 EPB41L3 SARNP MECP2 JMJD1C EMSY WDR43 DDX10 EFTUD2 ZNF512B RIF1 ZNF638 SMARCC2 DGCR8 TOR1AIP1 NPAT | 5.94e-10 | 954 | 175 | 23 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL27 TENT4B HSPA4L BCLAF1 IARS1 CAMK2B PCLO U2SURP ELP1 GTPBP1 SMC2 EPB41L3 WDR43 POLR3A DDX10 EFTUD2 RIF1 UBB UTP15 RAB3GAP2 MRPS9 HADHA HAX1 GALNT5 TOR1AIP1 HSPA4 CPSF3 GOLGA4 | 7.01e-10 | 1425 | 175 | 28 | 30948266 |
| Pubmed | MAP7D3 MYCBP2 ACAT2 BCLAF1 HAUS3 EPB41L3 ERBIN MECP2 ZNF512B ZNF8 UBB IGF2BP3 ZNF638 EXOC1 ALB HADHA MORC3 TOR1AIP1 CPSF3 | 8.08e-10 | 645 | 175 | 19 | 25281560 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL27 MYCBP2 ACAT2 IARS1 SEPTIN9 U2SURP ELP1 DDX51 SMC2 EPB41L3 ERBIN POLR3A DDX10 EFTUD2 RIF1 TBC1D4 SBF1 UTP15 A2ML1 ZNF638 SMARCC2 EXOC1 HADHA POLD3 HSPA4 CPSF3 GOLGA4 | 1.05e-09 | 1353 | 175 | 27 | 29467282 |
| Pubmed | COL5A1 RPL27 TENT4B BCLAF1 IARS1 U2SURP EVPL DDX51 SMC2 SARNP EFTUD2 ZNF512B RIF1 IGF2BP3 A2ML1 ZNF638 MRPS9 SMARCC2 HAX1 TOR1AIP1 CPSF3 | 2.15e-09 | 847 | 175 | 21 | 35850772 | |
| Pubmed | TEX2 BCLAF1 COPG2 EPB41L3 ERBIN JMJD1C C2CD2 UBC RAB3GAP2 SYNE2 TOR1AIP1 | 4.02e-09 | 191 | 175 | 11 | 31177093 | |
| Pubmed | AKAP6 MYCBP2 OBSCN ELP1 NEB JMJD1C ZNF181 UBB UBC NEO1 TBC1D4 XIRP2 AGL SYNE2 EXOC1 PLCE1 | 5.41e-09 | 497 | 175 | 16 | 23414517 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL27 MYCBP2 BCLAF1 ARRDC5 U2SURP EPB41L3 SARNP MECP2 EFTUD2 ZNF512B ZNF8 IGF2BP3 PTPN13 SBF1 KCTD10 PCDH15 MKX ZNF638 SMARCC2 ALB HADHA HAX1 CPSF3 | 6.41e-09 | 1082 | 175 | 23 | 38697112 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP7D3 CAMK4 BCLAF1 SEPTIN9 U2SURP COPG2 EPB41L3 ERBIN EMSY WDR43 DDX10 EFTUD2 ZNF512B RIF1 IGF2BP3 PTPN13 ZNF638 OGA TOR1AIP1 HSPA4 CPSF3 | 1.18e-08 | 934 | 175 | 21 | 33916271 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | IARS1 SEPTIN9 U2SURP SMC2 DDX10 EFTUD2 UBB UBC ZNF638 SMARCC2 HADHA SEPTIN10 | 1.49e-08 | 271 | 175 | 12 | 32433965 |
| Pubmed | MYCBP2 TRPS1 ELP1 COPG2 HID1 ERBIN ZNF512B POSTN PACS1 RFTN1 RIF1 PTPN13 TBC1D4 SBF1 SYNE2 VPS13A ZNF638 HADHA HAX1 DMD CPSF3 GOLGA4 | 1.79e-08 | 1049 | 175 | 22 | 27880917 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | HSPA4L BCLAF1 IARS1 U2SURP ELP1 DDX51 SMC2 RIF1 MRPS9 HADHA HSPA4 | 1.83e-08 | 221 | 175 | 11 | 29991511 |
| Pubmed | NRCAM MYCBP2 HSPA4L TEX2 CAMK2B PCLO ADGRB3 GTPBP1 EPB41L3 MECP2 ADCY5 RAB3GAP2 CEP170B | 2.67e-08 | 347 | 175 | 13 | 17114649 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL27 TENT4B BCLAF1 U2SURP DDX51 ERBIN JMJD1C WDR43 DDX10 EFTUD2 RFTN1 ZNF106 RIF1 UTP15 ZNF638 MRPS9 SMARCC2 HADHA DGCR8 HSPA4 CPSF3 | 3.14e-08 | 989 | 175 | 21 | 36424410 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 COL5A1 MYCBP2 CAMK2B SEPTIN9 TM7SF3 PCDH11Y TRPS1 OBSCN ERBIN ADCY3 JMJD1C C2CD2 NBPF1 SH3BP4 PACS1 TSC22D1 PTPN13 IGF1R TBC1D4 TTLL11 ZNF638 CEP170B RECK GOLGA4 DOP1A | 3.35e-08 | 1489 | 175 | 26 | 28611215 |
| Pubmed | BCLAF1 IARS1 SEPTIN9 EVPL EMSY PACS1 ZNF638 MRPS9 EXOC1 SEPTIN10 TOR1AIP1 HSPA4 GOLGA4 | 4.11e-08 | 360 | 175 | 13 | 33111431 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 BCLAF1 IARS1 SEPTIN9 U2SURP ELP1 SMC2 WDR43 DDX10 EFTUD2 ZNF512B RIF1 IGF2BP3 UBC SYNE2 ZNF638 SMARCC2 ALB HADHA TOR1AIP1 HSPA4 | 5.65e-08 | 1024 | 175 | 21 | 24711643 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL27 DNAH3 HSPA4L BCLAF1 IARS1 SEPTIN9 U2SURP ADGRB3 HAUS3 SMC2 POLR3A EFTUD2 SEPTIN8 UBB IGF2BP3 SMARCC2 SEPTIN10 HSPA4 DOP1A | 6.38e-08 | 847 | 175 | 19 | 35235311 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RPL27 MAP7D3 MYCBP2 TEX2 EPB41L3 ERBIN SH3BP4 ZNF106 PTPN13 IGF1R TBC1D4 SBF1 RAB3GAP2 SYNE2 MARK4 MORC3 CEP170B GOLGA4 DOP1A | 8.23e-08 | 861 | 175 | 19 | 36931259 |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | NRCAM ACAT2 CAMK2B SEPTIN9 PCLO EPB41L3 PACS1 TSC22D1 NEO1 CADPS | 8.70e-08 | 202 | 175 | 10 | 33601422 |
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 21129452 | ||
| Pubmed | 1.25e-07 | 3 | 175 | 3 | 21173574 | ||
| Pubmed | RPL27 ATP7A MAP7D3 HSPA4L BCLAF1 IARS1 SEPTIN9 COPG2 SMC2 EPB41L3 ERBIN JMJD1C PTPN13 RAB3GAP2 HADHA HSPA4 GOLGA4 | 1.26e-07 | 708 | 175 | 17 | 39231216 | |
| Pubmed | AKAP6 TEX2 OBSCN NSD1 COPG2 ERBIN ADCY3 F13A1 SEPTIN8 PACS1 MFAP3 UBC PTPN13 SCAP ABHD17B CLCNKA KCNJ8 CCNL1 MKX ZNF638 NPAT | 1.46e-07 | 1084 | 175 | 21 | 11544199 | |
| Pubmed | HSPA4L BCLAF1 GTPBP1 EPB41L3 DDX10 EFTUD2 IGF2BP3 SMARCC2 HADHA HSPA4 CPSF3 | 1.63e-07 | 274 | 175 | 11 | 34244482 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 IARS1 SEPTIN9 PCLO OBSCN EVPL FABP7 FRY IGF2BP3 TBC1D4 AGL VPS13A PKHD1 ALB HADHA RPE65 FBXO34 | 2.18e-07 | 736 | 175 | 17 | 29676528 |
| Pubmed | AKAP6 PRUNE2 MYCBP2 ADGRB3 ERBIN SCAP CADPS RAB3GAP2 SYNE2 OGA | 2.37e-07 | 225 | 175 | 10 | 12168954 | |
| Pubmed | 3.01e-07 | 87 | 175 | 7 | 33711283 | ||
| Pubmed | RPL27 MAP7D3 HSPA4L IARS1 U2SURP SMC2 SARNP MECP2 DDX10 EFTUD2 IGF2BP3 HADHA HSPA4 | 4.21e-07 | 441 | 175 | 13 | 31239290 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 BCLAF1 SEPTIN9 DDX51 ERBIN MECP2 EMSY EFTUD2 PACS1 ZNF106 RIF1 TBC1D4 CCNL1 ZNF638 SMARCC2 OGA GOLGA4 | 4.39e-07 | 774 | 175 | 17 | 15302935 |
| Pubmed | RPL27 NRCAM MYCBP2 BCLAF1 CAMK2B ADGRB3 NSD1 SMC2 EPB41L3 ERBIN EMSY EFTUD2 FRY SBF1 SYNE2 SMARCC2 CDH2 CEP170B GOLGA4 | 4.54e-07 | 963 | 175 | 19 | 28671696 | |
| Pubmed | 4.99e-07 | 4 | 175 | 3 | 22285186 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | TENT4A BCLAF1 ARRDC5 U2SURP SMC2 EPB41L3 PTPN13 ZNF638 HADHA DMD CPSF3 | 6.10e-07 | 313 | 175 | 11 | 38270169 |
| Pubmed | 7.46e-07 | 255 | 175 | 10 | 15324660 | ||
| Pubmed | 8.33e-07 | 199 | 175 | 9 | 23382691 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RPL27 MAP7D3 IARS1 SEPTIN9 PCLO HAUS3 EFTUD2 FRY UBB IGF2BP3 TBC1D4 SBF1 MRPS9 HADHA HAX1 | 9.51e-07 | 639 | 175 | 15 | 23443559 |
| Pubmed | NRCAM SEPTIN9 SPEG BEND3 ERBIN ADCY3 CADPS RAB3GAP2 ITSN2 MARK4 CEP170B PLCE1 | 1.19e-06 | 407 | 175 | 12 | 12693553 | |
| Pubmed | PRUNE2 EPB41L3 CLSTN1 JMJD1C PRX EFTUD2 RFTN1 TSC22D1 SCAP DNAH17 MORC3 DOP1A DCAF12 | 1.46e-06 | 493 | 175 | 13 | 15368895 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL27 MYCBP2 ACAT2 HSPA4L IARS1 SEPTIN9 U2SURP COPG2 SMC2 SARNP EFTUD2 SEPTIN8 IGF2BP3 TBC1D4 AGL RAB3GAP2 HADHA POLD3 OGA HSPA4 | 1.55e-06 | 1149 | 175 | 20 | 35446349 |
| Pubmed | 1.57e-06 | 277 | 175 | 10 | 30745168 | ||
| Pubmed | 1.89e-06 | 114 | 175 | 7 | 21150319 | ||
| Pubmed | 1.97e-06 | 284 | 175 | 10 | 29459677 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MAP7D3 MYCBP2 HSPA4L TEX2 PCLO ELP1 BEND3 WDR43 POLR3A ZNF512B UBB IGF2BP3 SLC25A40 UTP15 NDUFAF7 RAB3GAP2 SYNE2 ITSN2 VPS13A MRPS9 HADHA HAX1 TOR1AIP1 | 1.99e-06 | 1496 | 175 | 23 | 32877691 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | RPL27 MAP7D3 MYCBP2 BCLAF1 ERBIN EMSY EFTUD2 RIF1 IGF2BP3 ZNF638 TOR1AIP1 | 2.44e-06 | 361 | 175 | 11 | 30344098 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RPL27 BCLAF1 IARS1 U2SURP BEND3 DDX51 SARNP DDX10 EFTUD2 ZNF512B IGF2BP3 ZNF638 SMARCC2 ALB | 2.62e-06 | 605 | 175 | 14 | 28977666 |
| Pubmed | 3.02e-06 | 298 | 175 | 10 | 30737378 | ||
| Pubmed | 3.17e-06 | 234 | 175 | 9 | 36243803 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP7D3 MYCBP2 BCLAF1 IARS1 SEPTIN9 HAUS3 GTPBP1 EPB41L3 DDX10 SEPTIN8 IGF2BP3 PTPN13 SBF1 EXOC1 HADHA | 4.37e-06 | 724 | 175 | 15 | 36232890 |
| Pubmed | 4.45e-06 | 244 | 175 | 9 | 29884807 | ||
| Pubmed | 4.55e-06 | 130 | 175 | 7 | 12421765 | ||
| Pubmed | RPL27 HSPA4L BCLAF1 IARS1 SEPTIN9 U2SURP COPG2 SMC2 ERBIN SH3BP4 EFTUD2 UBB IGF2BP3 IGF1R TBC1D4 TTLL11 SMARCC2 HADHA POLD3 HSPA4 | 5.26e-06 | 1247 | 175 | 20 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPL27 MYCBP2 HSPA4L IARS1 CAMK2B U2SURP ELP1 HMGCR SMC2 POLR3A EFTUD2 RIF1 IGF2BP3 AGL HADHA HAX1 POLD3 OGA HSPA4 CPSF3 | 5.92e-06 | 1257 | 175 | 20 | 37317656 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BCLAF1 U2SURP TRPS1 HAUS3 WDR43 EFTUD2 ZNF8 PACS1 ZNF106 IGF2BP3 NDUFAF7 KCTD10 ITSN2 SMARCC2 HADHA MORC3 TOR1AIP1 CEP170B DCAF12 | 6.43e-06 | 1155 | 175 | 19 | 20360068 |
| Pubmed | 6.84e-06 | 327 | 175 | 10 | 31409639 | ||
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 6.88e-06 | 8 | 175 | 3 | 28826662 | |
| Pubmed | Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse. | 6.88e-06 | 8 | 175 | 3 | 16461637 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL27 TENT4B MAP7D3 MYCBP2 DDX51 GTPBP1 SMC2 SARNP WDR43 DDX10 RIF1 IGF2BP3 UBC UTP15 DGCR8 | 7.67e-06 | 759 | 175 | 15 | 35915203 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYCBP2 ACAT2 HSPA4L BCLAF1 IARS1 CAMK2B COPG2 SMC2 EPB41L3 JMJD1C SH3BP4 EFTUD2 SEPTIN8 TSC22D1 IGF2BP3 IGF1R TBC1D4 RAB3GAP2 MRPS9 HADHA | 8.08e-06 | 1284 | 175 | 20 | 17353931 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SEPTIN9 U2SURP ELP1 COPG2 GTPBP1 SMC2 EPB41L3 EFTUD2 RIF1 ZNF638 SMARCC2 EXOC1 CPSF3 | 8.79e-06 | 582 | 175 | 13 | 20467437 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | RPL27 HSPA4L BCLAF1 U2SURP TRPS1 BEND3 GTPBP1 EPB41L3 POLR3A EFTUD2 RIF1 UBC ALB | 8.95e-06 | 583 | 175 | 13 | 29844126 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL27 MAP7D3 BCLAF1 U2SURP NSD1 BEND3 DDX51 SMC2 MECP2 JMJD1C EMSY WDR43 EFTUD2 ZNF512B ZNF106 RIF1 ZNF638 HADHA TOR1AIP1 CPSF3 | 9.05e-06 | 1294 | 175 | 20 | 30804502 |
| Pubmed | MYCBP2 TRPS1 BEND3 COPG2 EPB41L3 JMJD1C ZNF8 PTPN13 TBC1D4 RAB3GAP2 NPAT | 9.76e-06 | 418 | 175 | 11 | 34709266 | |
| Pubmed | 9.93e-06 | 27 | 175 | 4 | 21343306 | ||
| Pubmed | 1.03e-05 | 9 | 175 | 3 | 16763556 | ||
| Pubmed | RPL27 TENT4B NRCAM BCLAF1 U2SURP SIDT1 NEB EMSY NBPF1 EFTUD2 IGF2BP3 CADPS | 1.25e-05 | 513 | 175 | 12 | 25798074 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | RPL27 HSPA4L BCLAF1 MECP2 WDR43 DDX10 EFTUD2 UTP15 VPS13A ALB HSPA4 | 1.27e-05 | 430 | 175 | 11 | 38172120 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 1.38e-05 | 154 | 175 | 7 | 16055720 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NSD1 MECP2 JMJD1C EMSY WDR43 DDX10 ZNF512B ZNF8 RIF1 CCNL1 SMARCC2 MORC3 NPAT | 1.39e-05 | 608 | 175 | 13 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.46e-05 | 283 | 175 | 9 | 30585729 | |
| Pubmed | 1.59e-05 | 105 | 175 | 6 | 24667918 | ||
| Pubmed | 1.81e-05 | 222 | 175 | 8 | 35941108 | ||
| Pubmed | RPL27 IARS1 COPG2 IGF2BP3 TBC1D4 AGL RAB3GAP2 HADHA HAX1 POLD3 OGA TOR1AIP1 | 1.85e-05 | 534 | 175 | 12 | 35032548 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RPL27 PODXL BCLAF1 IARS1 SEPTIN9 GTPBP1 SMC2 EPB41L3 ERBIN EMSY EFTUD2 UTP15 AGL SYNE2 A2ML1 EXOC1 HADHA TOR1AIP1 HSPA4 CPSF3 | 1.99e-05 | 1367 | 175 | 20 | 32687490 |
| Pubmed | RPL27 BCLAF1 IARS1 U2SURP SMC2 SARNP RIF1 UBB TBC1D4 DMD SEPTIN10 HSPA4 | 1.99e-05 | 538 | 175 | 12 | 28524877 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 2.00e-05 | 32 | 175 | 4 | 22424883 | |
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 2.01e-05 | 11 | 175 | 3 | 15905963 | |
| Pubmed | TENT4B TENT4A CAMK4 BCLAF1 CAMK2B NSD1 POLR3A UBB UBC IGF1R AK5 KCTD10 DNAH17 GALNT5 | 2.17e-05 | 730 | 175 | 14 | 34857952 | |
| Pubmed | MYCBP2 TEX2 HMGCR ERBIN JMJD1C ZNF106 NEO1 SCAP RAB3GAP2 ZNF638 POLD3 TOR1AIP1 CPSF3 GOLGA4 | 2.27e-05 | 733 | 175 | 14 | 34672954 | |
| Pubmed | TENT4B TRPS1 NSD1 COPG2 DDX51 ERBIN MECP2 EMSY WDR43 DDX10 RFTN1 RIF1 PTPN13 SBF1 SLC25A40 UTP15 CGREF1 ITSN2 CCNL1 DGCR8 CEP170B | 2.27e-05 | 1497 | 175 | 21 | 31527615 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ATP7A EPB41L3 ERBIN ADCY3 SH3BP4 PACS1 RFTN1 PTPN13 DMD TOR1AIP1 | 2.33e-05 | 377 | 175 | 10 | 38117590 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.40e-05 | 231 | 175 | 8 | 16452087 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 9644242 | ||
| Pubmed | Essential role of obscurin kinase-1 in cardiomyocyte coupling via N-cadherin phosphorylation. | 2.52e-05 | 2 | 175 | 2 | 38127465 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 25687328 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 22775139 | ||
| Pubmed | Hybrid troponin reconstituted from vertebrate and arthropod subunits. | 2.52e-05 | 2 | 175 | 2 | 124018 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 32705536 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 11173499 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21903813 | ||
| Pubmed | Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala. | 2.52e-05 | 2 | 175 | 2 | 22592879 | |
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 21276771 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 33600816 | ||
| Pubmed | 2.52e-05 | 2 | 175 | 2 | 23868268 | ||
| Pubmed | An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes. | 2.52e-05 | 2 | 175 | 2 | 19574217 | |
| Interaction | KCTD13 interactions | RPL27 NRCAM HSPA4L BCLAF1 IARS1 CAMK2B SEPTIN9 PCLO ELP1 GTPBP1 EPB41L3 ERBIN MECP2 SLC4A1 FABP7 SEPTIN8 PACS1 SBF1 CADPS KCTD10 ITSN2 MRPS9 SMARCC2 EXOC1 ALB HADHA HAX1 DMD CDH2 HSPA4 CEP170B | 1.15e-06 | 1394 | 175 | 31 | int:KCTD13 |
| Interaction | SIRT7 interactions | COL5A1 MYCBP2 U2SURP NSD1 ELP1 BEND3 COPG2 DDX51 EPB41L3 WDR43 DDX10 RIF1 IGF2BP3 SBF1 UTP15 SYNE2 ZNF638 SMARCC2 HADHA HSPA4 CPSF3 | 2.09e-06 | 744 | 175 | 21 | int:SIRT7 |
| Interaction | ARL14 interactions | 9.52e-06 | 119 | 175 | 8 | int:ARL14 | |
| Interaction | DROSHA interactions | 1.08e-05 | 87 | 175 | 7 | int:DROSHA | |
| Interaction | HECTD1 interactions | RPL27 TENT4B MAP7D3 MYCBP2 HSPA4L U2SURP DDX51 GTPBP1 SMC2 EPB41L3 SARNP WDR43 POLR3A DDX10 EFTUD2 RIF1 IGF2BP3 UBC UTP15 EXOC1 DGCR8 CDH2 HSPA4 | 1.49e-05 | 984 | 175 | 23 | int:HECTD1 |
| Interaction | MECP2 interactions | RPL27 MYCBP2 BCLAF1 CAMK2B ARRDC5 U2SURP NSD1 DDX51 EPB41L3 SARNP MECP2 EFTUD2 ZNF512B ZNF8 IGF2BP3 PTPN13 SBF1 KCTD10 PCDH15 MKX ZNF638 SMARCC2 ALB HADHA DGCR8 HAX1 CPSF3 | 1.78e-05 | 1287 | 175 | 27 | int:MECP2 |
| Interaction | SMC5 interactions | RPL27 MAP7D3 BCLAF1 SEPTIN9 U2SURP NSD1 BEND3 COPG2 EPB41L3 SARNP MECP2 JMJD1C EMSY WDR43 DDX10 EFTUD2 ZNF512B RIF1 ZNF638 SMARCC2 DGCR8 TOR1AIP1 NPAT | 1.93e-05 | 1000 | 175 | 23 | int:SMC5 |
| Interaction | HDAC2 interactions | MYCBP2 PODXL SEPTIN9 TRPS1 BEND3 SMC2 MECP2 JMJD1C EMSY POLR3A EFTUD2 ZNF512B IGF2BP3 TMEM132D SMARCC2 ALB HADHA POLD3 DMD HSPA4 GOLGA4 | 2.08e-05 | 865 | 175 | 21 | int:HDAC2 |
| Interaction | KCNA3 interactions | RPL27 ATP7A MAP7D3 HSPA4L BCLAF1 IARS1 SEPTIN9 COPG2 SMC2 EPB41L3 ERBIN JMJD1C PTPN13 TBC1D4 RAB3GAP2 VPS13A PKHD1 HADHA HSPA4 GOLGA4 DOP1A | 2.30e-05 | 871 | 175 | 21 | int:KCNA3 |
| Interaction | DOT1L interactions | COL5A1 RPL27 TENT4B IARS1 U2SURP EVPL DDX51 SMC2 SARNP EFTUD2 ZNF512B RIF1 IGF2BP3 A2ML1 ZNF638 MRPS9 SMARCC2 HAX1 TOR1AIP1 CPSF3 | 2.48e-05 | 807 | 175 | 20 | int:DOT1L |
| Interaction | ADARB1 interactions | RPL27 TENT4B IARS1 SEPTIN9 U2SURP DDX51 SMC2 DDX10 EFTUD2 UBB ZNF638 MRPS9 SMARCC2 HADHA SEPTIN10 | 2.51e-05 | 489 | 175 | 15 | int:ADARB1 |
| Interaction | PARP1 interactions | RPL27 TENT4B MYCBP2 CAMK2B SEPTIN9 U2SURP NSD1 BEND3 DDX51 SMC2 MECP2 WDR43 SH3BP4 DDX10 EFTUD2 ZNF512B ZNF106 UBC PTPN13 RAB3GAP2 MRPS9 SMARCC2 HADHA DGCR8 MORC3 HSPA4 RAD54L | 2.64e-05 | 1316 | 175 | 27 | int:PARP1 |
| Interaction | TERF2IP interactions | U2SURP NSD1 BEND3 SARNP EMSY PRX DDX10 ZNF512B RIF1 ZNF638 SMARCC2 DGCR8 POLD3 TOR1AIP1 HSPA4 NPAT | 2.67e-05 | 552 | 175 | 16 | int:TERF2IP |
| Interaction | MEN1 interactions | COL5A1 RPL27 TENT4B BCLAF1 IARS1 U2SURP TRPS1 DDX51 SMC2 ERBIN JMJD1C EMSY DDX10 EFTUD2 ZNF512B RIF1 IGF2BP3 ZNF638 MRPS9 SMARCC2 TOR1AIP1 HSPA4 CPSF3 | 3.02e-05 | 1029 | 175 | 23 | int:MEN1 |
| Interaction | YWHAH interactions | RPL27 MAP7D3 MYCBP2 TEX2 SPEG EPB41L3 ERBIN RNF115 SH3BP4 EFTUD2 PACS1 ZNF106 PTPN13 TBC1D4 SBF1 RAB3GAP2 SYNE2 MARK4 ZNF638 MORC3 HSPA4 CEP170B GOLGA4 DOP1A | 3.03e-05 | 1102 | 175 | 24 | int:YWHAH |
| Interaction | HDAC1 interactions | MYCBP2 TRPS1 BEND3 COPG2 SMC2 EPB41L3 MECP2 JMJD1C EMSY POLR3A EFTUD2 ZNF512B ZNF8 PTPN13 TBC1D4 RAB3GAP2 SYNE2 MKX ZNF638 SMARCC2 POLD3 HSPA4 GOLGA4 NPAT | 3.31e-05 | 1108 | 175 | 24 | int:HDAC1 |
| Interaction | NAA40 interactions | MAP7D3 CAMK4 BCLAF1 SEPTIN9 U2SURP COPG2 EPB41L3 ERBIN MECP2 EMSY WDR43 DDX10 EFTUD2 ZNF512B RIF1 IGF2BP3 PTPN13 ZNF638 OGA TOR1AIP1 HSPA4 CPSF3 | 4.15e-05 | 978 | 175 | 22 | int:NAA40 |
| Interaction | EED interactions | RPL27 MYCBP2 BCLAF1 IARS1 SEPTIN9 OBSCN NSD1 ELP1 DDX51 SMC2 WDR43 SH3BP4 DDX10 EFTUD2 ZNF512B RIF1 TSC22D1 IGF1R XIRP2 RAB3GAP2 ITSN2 ZNF638 SMARCC2 ALB HADHA MORC3 CPSF3 CEP170B | 5.08e-05 | 1445 | 175 | 28 | int:EED |
| Interaction | YWHAG interactions | MAP7D3 MYCBP2 BCLAF1 SPEG EPB41L3 ERBIN RNF115 SH3BP4 EFTUD2 PACS1 ZNF106 UBB PTPN13 IGF1R TBC1D4 SBF1 SYNE2 MARK4 ZNF638 ALB MORC3 HSPA4 CPSF3 CEP170B DOP1A | 7.96e-05 | 1248 | 175 | 25 | int:YWHAG |
| Interaction | TEDC2 interactions | 8.16e-05 | 206 | 175 | 9 | int:TEDC2 | |
| Interaction | DRP2 interactions | 1.01e-04 | 11 | 175 | 3 | int:DRP2 | |
| Interaction | RNF123 interactions | DNAH3 IARS1 SEPTIN9 PCLO OBSCN EVPL FABP7 FRY IGF2BP3 UBC TBC1D4 AGL VPS13A PKHD1 ALB HADHA MORC3 RPE65 FBXO34 | 1.04e-04 | 824 | 175 | 19 | int:RNF123 |
| Interaction | RCOR1 interactions | MYCBP2 TRPS1 BEND3 COPG2 SMC2 EPB41L3 MECP2 JMJD1C ZNF8 PTPN13 RAB3GAP2 SMARCC2 HSPA4 NPAT | 1.09e-04 | 494 | 175 | 14 | int:RCOR1 |
| Interaction | H3C1 interactions | U2SURP NSD1 NEB SARNP MECP2 JMJD1C DDX10 EFTUD2 ZNF512B RIF1 UBB XIRP2 TMEM132D PCDH11X ZNF638 MRPS9 SMARCC2 HADHA POLD3 MORC3 | 1.14e-04 | 901 | 175 | 20 | int:H3C1 |
| Interaction | GLDC interactions | HSPA4L BCLAF1 GTPBP1 EPB41L3 DDX10 EFTUD2 IGF2BP3 SMARCC2 HADHA HSPA4 CPSF3 | 1.19e-04 | 321 | 175 | 11 | int:GLDC |
| Interaction | GRWD1 interactions | HSPA4L BCLAF1 IARS1 U2SURP ELP1 DDX51 SMC2 EFTUD2 RIF1 MRPS9 HADHA HSPA4 | 1.61e-04 | 390 | 175 | 12 | int:GRWD1 |
| Cytoband | 11q22-q23 | 2.17e-04 | 6 | 176 | 2 | 11q22-q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p23 | 2.87e-04 | 149 | 176 | 5 | chr2p23 | |
| GeneFamily | Non-clustered protocadherins | 4.89e-05 | 12 | 112 | 3 | 21 | |
| GeneFamily | Septins | 6.33e-05 | 13 | 112 | 3 | 732 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 7.83e-04 | 7 | 112 | 2 | 917 | |
| GeneFamily | Non-canonical poly(A) polymerases | 7.83e-04 | 7 | 112 | 2 | 1318 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.42e-03 | 36 | 112 | 3 | 823 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.66e-03 | 10 | 112 | 2 | 53 | |
| GeneFamily | PDZ domain containing | 2.56e-03 | 152 | 112 | 5 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.28e-03 | 161 | 112 | 5 | 593 | |
| GeneFamily | Dyneins, axonemal | 4.87e-03 | 17 | 112 | 2 | 536 | |
| GeneFamily | Cadherin related | 4.87e-03 | 17 | 112 | 2 | 24 | |
| GeneFamily | Heat shock 70kDa proteins | 4.87e-03 | 17 | 112 | 2 | 583 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 PODXL SEPTIN9 U2SURP MECP2 C2CD2 WDR43 DDX10 RFTN1 RIF1 IGF2BP3 PTPN13 IGF1R SYNE2 ITSN2 VPS13A ZNF638 DMD CDH2 GOLGA4 PLCE1 NPAT | 6.93e-08 | 856 | 175 | 22 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYCBP2 HSPA4L PODXL BCLAF1 IARS1 TM7SF3 HAUS3 SMC2 EPB41L3 DDX10 RIF1 PTPN13 SYNE2 ITSN2 CCNL1 ZNF638 EXOC1 GOLGA4 PUS7L | 9.36e-08 | 656 | 175 | 19 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | PRUNE2 PCLO TRPS1 EPB41L3 IGF1R SYNE2 VPS13A PCDH15 PKHD1 OGA GOLGA4 | 3.05e-07 | 221 | 175 | 11 | M39222 |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 4.42e-06 | 64 | 175 | 6 | M4594 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | DENND5B PRUNE2 NRCAM MYCBP2 HSPA4L SPEG PCLO U2SURP EPB41L3 ZNF106 UBC NEO1 IGF1R TBC1D4 CADPS SYNE2 PLCXD3 HAX1 TOR1AIP1 GOLGA4 | 5.66e-06 | 946 | 175 | 20 | M39169 |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 7.50e-06 | 197 | 175 | 9 | M8983 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 8.13e-06 | 199 | 175 | 9 | M4444 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 8.47e-06 | 200 | 175 | 9 | M4449 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | HSPA4L BCLAF1 ADAMTS5 FABP7 POSTN RIF1 IGF2BP3 ADGRG2 CADPS AVIL DMD HSPA4 | 1.87e-05 | 404 | 175 | 12 | M19488 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ABHD17A RPL27 MAP7D3 MYCBP2 BCLAF1 SEPTIN9 U2SURP TRPS1 NSD1 ELP1 ERBIN MECP2 JMJD1C PACS1 RFTN1 RIF1 UBC TBC1D4 RAB3GAP2 ITSN2 CCNL1 ZNF638 OGA TOR1AIP1 NPAT | 2.06e-05 | 1492 | 175 | 25 | M40023 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | ABHD17A ATP7A PODXL SPEG PCLO TM7SF3 ADAMTS5 ERBIN SH3BP4 ZNF512B FRY NEO1 SCAP MMEL1 ITSN2 VPS13A CDH2 RECK PLCE1 | 2.28e-05 | 955 | 175 | 19 | M45680 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 3.05e-05 | 235 | 175 | 9 | M2256 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | TENT4A MECP2 RIF1 IGF2BP3 VPS13A ZNF638 POLD3 MORC3 DOP1A NPAT | 3.60e-05 | 300 | 175 | 10 | M8702 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL5A1 MAP7D3 OBSCN ADGRB3 ADAMTS5 POSTN RFTN1 FRY XIRP2 KCNJ8 SCN7A DMD RECK | 3.73e-05 | 505 | 175 | 13 | M39167 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | PRUNE2 ATP7A MYCBP2 ACAT2 BCLAF1 HMGCR LEP F13A1 NEO1 CCNL1 TOR1AIP1 | 5.18e-05 | 379 | 175 | 11 | M1885 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 5.62e-05 | 197 | 175 | 8 | M5378 | |
| Coexpression | ERBB2_UP.V1_DN | 5.62e-05 | 197 | 175 | 8 | M2635 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 6.25e-05 | 200 | 175 | 8 | M3390 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN | 6.25e-05 | 200 | 175 | 8 | M4583 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 6.25e-05 | 200 | 175 | 8 | M4456 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 SEPTIN9 U2SURP MECP2 C2CD2 WDR43 RFTN1 IGF2BP3 ITSN2 VPS13A ZNF638 GOLGA4 | 7.45e-05 | 466 | 175 | 12 | M13522 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | ARMC3 OBSCN ITGA8 GTPBP1 MECP2 F13A1 POLR3A NBPF1 ADGRG7 IGF1R TBC1D4 TMEM132D AK5 A2ML1 DMD DOP1A PUS7L | 8.17e-05 | 873 | 175 | 17 | M16009 |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 9.59e-05 | 158 | 175 | 7 | M372 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.49e-04 | 289 | 175 | 9 | M2196 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | TENT4A BCLAF1 U2SURP HAUS3 DDX51 JMJD1C ZNF512B IGF1R CCNL1 OGA GOLGA4 | 1.64e-04 | 432 | 175 | 11 | M41149 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AKAP6 NRCAM MYCBP2 CAMK4 TRPS1 ADGRB3 NSD1 ITGA8 ADAMTS5 SMC2 EPB41L3 FABP7 RIF1 CADPS CERS3 PCDH11X MKX PLCXD3 OGA CDH2 RAD54L | 3.72e-06 | 818 | 174 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | MAP7D3 PODXL SEPTIN9 TRPS1 ITGA8 EPB41L3 FREM1 FABP7 POSTN NEO1 PTPN13 TBC1D4 PCDH11X ALB HADHA CDH2 PCDH9 RECK PLCE1 | 3.10e-05 | 797 | 174 | 19 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.51e-05 | 202 | 174 | 9 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | TRPS1 ADGRB3 ITGA8 SMC2 F13A1 ADGRG2 KCNJ8 PKHD1 GALNT5 PCDH9 | 5.20e-05 | 256 | 174 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NRCAM PCLO OBSCN NEB FREM1 XIRP2 PCDH11X PCDH15 PKHD1 DMD PLCE1 | 1.90e-10 | 184 | 175 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NRCAM PCLO OBSCN NEB FREM1 XIRP2 PCDH11X PCDH15 PKHD1 DMD PLCE1 | 1.90e-10 | 184 | 175 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NRCAM PCLO OBSCN NEB FREM1 XIRP2 PCDH11X PCDH15 PKHD1 DMD PLCE1 | 1.90e-10 | 184 | 175 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | AKAP6 CAMK2B OBSCN ADCY5 FRY XIRP2 CADPS PLCXD3 DMD CDH2 PCDH9 | 2.01e-10 | 185 | 175 | 11 | 549eeb521c3985bff396ea0f202db21822efa51f |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | AKAP6 PRUNE2 CAMK2B OBSCN NEB TSC22D1 IGF1R CADPS DMD CDH2 PLCE1 | 2.39e-10 | 188 | 175 | 11 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | AKAP6 NSD1 ERBIN JMJD1C ZNF106 TBC1D4 XIRP2 ZNF638 HADHA DMD | 2.13e-09 | 176 | 175 | 10 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-09 | 183 | 175 | 10 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 BCLAF1 NSD1 ERBIN JMJD1C ZNF106 ITSN2 CCNL1 ZNF638 GOLGA4 | 3.27e-09 | 184 | 175 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.27e-09 | 184 | 175 | 10 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 TRPS1 NSD1 ERBIN JMJD1C F13A1 ZNF106 ITSN2 CCNL1 ZNF638 | 3.44e-09 | 185 | 175 | 10 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.45e-09 | 190 | 175 | 10 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ATP7A NRCAM CAMK2B ADGRB3 ADCY5 POSTN TBC1D4 CLCNKA ADGRG2 CDH2 | 4.68e-09 | 191 | 175 | 10 | 8f4637e801554e2343b974fe7794f01dd2151418 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 PCLO NSD1 HMGCR EPB41L3 RIF1 CADPS VPS13A CDH2 GOLGA4 | 5.71e-09 | 195 | 175 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.29e-09 | 197 | 175 | 10 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NRCAM CAMK2B PCLO ADGRB3 COPG2 TSC22D1 FRY CADPS PCDH11X SNTG1 | 6.60e-09 | 198 | 175 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.87e-08 | 164 | 175 | 9 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-08 | 170 | 175 | 9 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.97e-08 | 173 | 175 | 9 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.97e-08 | 173 | 175 | 9 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.39e-08 | 181 | 175 | 9 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.05e-08 | 184 | 175 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.36e-08 | 189 | 175 | 9 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-08 | 189 | 175 | 9 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-08 | 189 | 175 | 9 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.31e-08 | 195 | 175 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-08 | 195 | 175 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-08 | 198 | 175 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.41e-07 | 160 | 175 | 8 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.77e-07 | 163 | 175 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.34e-07 | 167 | 175 | 8 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-07 | 168 | 175 | 8 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-07 | 169 | 175 | 8 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.77e-07 | 175 | 175 | 8 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.98e-07 | 176 | 175 | 8 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.19e-07 | 177 | 175 | 8 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 182 | 175 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 182 | 175 | 8 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-07 | 182 | 175 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.68e-07 | 183 | 175 | 8 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-07 | 183 | 175 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-07 | 183 | 175 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.97e-07 | 184 | 175 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.97e-07 | 184 | 175 | 8 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-07 | 184 | 175 | 8 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-07 | 185 | 175 | 8 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.26e-07 | 185 | 175 | 8 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.26e-07 | 185 | 175 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.87e-07 | 187 | 175 | 8 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 7.87e-07 | 187 | 175 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 7.87e-07 | 187 | 175 | 8 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-07 | 187 | 175 | 8 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.19e-07 | 188 | 175 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.19e-07 | 188 | 175 | 8 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.87e-07 | 190 | 175 | 8 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 8.87e-07 | 190 | 175 | 8 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-07 | 191 | 175 | 8 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-07 | 191 | 175 | 8 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 9.23e-07 | 191 | 175 | 8 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-07 | 192 | 175 | 8 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-07 | 192 | 175 | 8 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-07 | 192 | 175 | 8 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.98e-07 | 193 | 175 | 8 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.98e-07 | 193 | 175 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 194 | 175 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.04e-06 | 194 | 175 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 1.04e-06 | 194 | 175 | 8 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-06 | 194 | 175 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.08e-06 | 195 | 175 | 8 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-06 | 196 | 175 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 196 | 175 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-06 | 196 | 175 | 8 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-06 | 196 | 175 | 8 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-06 | 197 | 175 | 8 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 197 | 175 | 8 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-06 | 197 | 175 | 8 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.16e-06 | 197 | 175 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 198 | 175 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-06 | 198 | 175 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 198 | 175 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-06 | 198 | 175 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-06 | 198 | 175 | 8 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-06 | 199 | 175 | 8 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 1.26e-06 | 199 | 175 | 8 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-06 | 200 | 175 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-06 | 155 | 175 | 7 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.24e-06 | 159 | 175 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 161 | 175 | 7 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-06 | 161 | 175 | 7 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.48e-06 | 167 | 175 | 7 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-06 | 168 | 175 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-06 | 168 | 175 | 7 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-06 | 168 | 175 | 7 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.23e-06 | 171 | 175 | 7 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| Drug | AC1Q6A8A | 1.50e-05 | 7 | 174 | 3 | CID000160255 | |
| Drug | L2-G | 1.50e-05 | 7 | 174 | 3 | CID009549184 | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 1.69e-05 | 191 | 174 | 9 | 7397_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.92e-05 | 194 | 174 | 9 | 1293_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.08e-05 | 196 | 174 | 9 | 7477_DN | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 2060_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 198 | 174 | 9 | 6260_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; HL60; HG-U133A | 2.34e-05 | 199 | 174 | 9 | 1440_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; PC3; HT_HG-U133A | 2.34e-05 | 199 | 174 | 9 | 5772_UP | |
| Disease | Malignant neoplasm of breast | AKAP6 NRCAM OBSCN ELP1 EPB41L3 RNF115 LEP EMSY FABP7 DDX10 RIF1 IGF1R SYNE2 ITSN2 GALNT5 DMD CDH2 TOR1AIP1 CPSF3 RAD54L DOP1A | 1.09e-06 | 1074 | 170 | 21 | C0006142 |
| Disease | reticulocyte measurement | HSPA4L SEPTIN9 U2SURP TRPS1 BEND3 ZC3H11B ADCY3 JMJD1C SLC4A1 PACS1 AK5 DNAH17 SYNE2 MARK4 VPS13A RORB HSPA4 FBXO34 DCAF12 | 1.15e-05 | 1053 | 170 | 19 | EFO_0010700 |
| Disease | Zollinger-Ellison syndrome (is_marker_for) | 3.30e-05 | 2 | 170 | 2 | DOID:0050782 (is_marker_for) | |
| Disease | Abnormality of refraction | AKAP6 COL5A1 PCDHA9 SEPTIN9 PCLO ZC3H11B ADCY5 FRY IGF1R RORB PLCXD3 CDH2 TOR1AIP1 PCDH9 | 3.83e-05 | 673 | 170 | 14 | HP_0000539 |
| Disease | Liver Cirrhosis, Experimental | CYBB PRUNE2 COL5A1 U2SURP HMGCR SMC2 LEP FABP7 TSC22D1 FRY IGF2BP3 AGL KCNJ8 ALB RECK | 4.52e-05 | 774 | 170 | 15 | C0023893 |
| Disease | N-palmitoyl-sphinganine (d18:0/16:0) measurement | 9.86e-05 | 3 | 170 | 2 | EFO_0800428 | |
| Disease | body fat percentage | TRPS1 ZC3H11B ADCY3 ADCY5 SLC4A1 PACS1 MFAP3 AK5 PKHD1 RORB PLCE1 | 1.32e-04 | 488 | 170 | 11 | EFO_0007800 |
| Disease | C-reactive protein measurement | AKAP6 TRPS1 HID1 GTPBP1 ADCY3 ADCY5 PACS1 ZNF106 IGF2BP3 NEO1 AK5 DNAH17 CCNL1 MARK4 PCDH15 SMARCC2 HAX1 TAF4B | 2.19e-04 | 1206 | 170 | 18 | EFO_0004458 |
| Disease | serum IgG glycosylation measurement | ARMC3 TRPS1 FRY IGF2BP3 SBF1 TMEM132D CADPS SNTG1 RPE65 CEP170B RECK | 2.40e-04 | 523 | 170 | 11 | EFO_0005193 |
| Disease | Mammary Carcinoma, Human | NRCAM ELP1 EPB41L3 RNF115 LEP EMSY FABP7 IGF1R ITSN2 CDH2 RAD54L | 2.48e-04 | 525 | 170 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NRCAM ELP1 EPB41L3 RNF115 LEP EMSY FABP7 IGF1R ITSN2 CDH2 RAD54L | 2.48e-04 | 525 | 170 | 11 | C1257931 |
| Disease | Mammary Neoplasms | NRCAM ELP1 EPB41L3 RNF115 LEP EMSY FABP7 IGF1R ITSN2 CDH2 RAD54L | 2.56e-04 | 527 | 170 | 11 | C1458155 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.77e-04 | 364 | 170 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Breast Carcinoma | NRCAM ELP1 EPB41L3 RNF115 LEP EMSY FABP7 IGF1R ITSN2 CDH2 RAD54L | 3.05e-04 | 538 | 170 | 11 | C0678222 |
| Disease | Wilson disease (implicated_via_orthology) | 3.26e-04 | 5 | 170 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Congenital absence of kidneys syndrome | 3.26e-04 | 5 | 170 | 2 | C1609433 | |
| Disease | chemokine (C-X-C motif) ligand 1 measurement | 3.26e-04 | 5 | 170 | 2 | EFO_0008083 | |
| Disease | Duchenne and Becker Muscular Dystrophy | 3.26e-04 | 5 | 170 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 3.26e-04 | 5 | 170 | 2 | C0917713 | |
| Disease | nephrotic syndrome (is_implicated_in) | 3.26e-04 | 5 | 170 | 2 | DOID:1184 (is_implicated_in) | |
| Disease | reticulocyte count | SEPTIN9 U2SURP TRPS1 BEND3 ZC3H11B ADCY3 JMJD1C SLC4A1 DNAH17 SYNE2 MARK4 VPS13A HAX1 HSPA4 FBXO34 DCAF12 | 3.76e-04 | 1045 | 170 | 16 | EFO_0007986 |
| Disease | neuroticism measurement, cognitive function measurement | PCDHA9 PCLO TRPS1 NXPE2 ADCY3 JMJD1C SCAP TTLL11 ZNF638 OGA PCDH9 | 4.67e-04 | 566 | 170 | 11 | EFO_0007660, EFO_0008354 |
| Disease | Muscular Dystrophy, Duchenne | 4.88e-04 | 6 | 170 | 2 | C0013264 | |
| Disease | glucose tolerance test | 4.96e-04 | 27 | 170 | 3 | EFO_0004307 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 5.48e-04 | 65 | 170 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | peripheral neuropathy | 6.80e-04 | 7 | 170 | 2 | EFO_0003100 | |
| Disease | Obesity, Morbid | 6.80e-04 | 7 | 170 | 2 | C0028756 | |
| Disease | right ventricular ejection fraction measurement | 6.80e-04 | 30 | 170 | 3 | EFO_0021816 | |
| Disease | waist-hip ratio | PRUNE2 COL5A1 MYCBP2 NSD1 ZC3H11B ADCY3 JMJD1C ADCY5 IGF1R CADPS DNAH17 SYNE2 MKX POLD3 HSPA4 IQUB PLCE1 | 7.55e-04 | 1226 | 170 | 17 | EFO_0004343 |
| Disease | mean reticulocyte volume | VSIG4 BEND3 CASTOR2 GTPBP1 NEB JMJD1C SLC4A1 TBC1D4 AK5 MARK4 VPS13A ZNF638 HSPA4 | 7.72e-04 | 799 | 170 | 13 | EFO_0010701 |
| Disease | Colorectal Carcinoma | AKAP6 DNAH3 NRCAM OBSCN POSTN VPS13A PCDH11X PKHD1 B4GALNT2 POLD3 DMD IQUB | 8.05e-04 | 702 | 170 | 12 | C0009402 |
| Disease | premature menopause (biomarker_via_orthology) | 9.03e-04 | 8 | 170 | 2 | DOID:10787 (biomarker_via_orthology) | |
| Disease | microcephaly (is_implicated_in) | 9.03e-04 | 8 | 170 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | urate measurement, bone density | AKAP6 COL5A1 PODXL ADGRB3 ERBIN FREM1 DDX10 A2ML1 MARK4 TAF4B SEPTIN10 | 9.72e-04 | 619 | 170 | 11 | EFO_0003923, EFO_0004531 |
| Disease | abdominal fat cell number | 1.04e-03 | 198 | 170 | 6 | EFO_0021534 | |
| Disease | osteoarthritis (is_marker_for) | 1.07e-03 | 35 | 170 | 3 | DOID:8398 (is_marker_for) | |
| Disease | plasma renin activity measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0006828 | |
| Disease | Headache, glucose measurement | 1.16e-03 | 9 | 170 | 2 | EFO_0004468, HP_0002315 | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.16e-03 | 9 | 170 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.20e-03 | 447 | 170 | 9 | C3714756 | |
| Disease | fasting blood glucose measurement | 1.43e-03 | 287 | 170 | 7 | EFO_0004465 | |
| Disease | age at menarche, spine bone mineral density | 1.44e-03 | 10 | 170 | 2 | EFO_0004703, EFO_0007701 | |
| Disease | neuroblastoma (is_implicated_in) | 1.44e-03 | 10 | 170 | 2 | DOID:769 (is_implicated_in) | |
| Disease | platelet component distribution width | PRUNE2 ARMC3 TENT4A SEPTIN9 U2SURP RNF115 JMJD1C ADCY5 SEPTIN8 IGF1R MARK4 DCAF12 | 1.50e-03 | 755 | 170 | 12 | EFO_0007984 |
| Disease | fat body mass | 1.67e-03 | 217 | 170 | 6 | EFO_0005409 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.75e-03 | 11 | 170 | 2 | EFO_0801871 | |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.75e-03 | 11 | 170 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | periodontitis | 1.91e-03 | 223 | 170 | 6 | EFO_0000649 | |
| Disease | sexual dimorphism measurement | PODXL TRPS1 NSD1 ZC3H11B HMGCR ADCY3 JMJD1C SLC4A1 PACS1 IGF2BP3 IGF1R AK5 AVIL RASGEF1B ZNF638 | 1.92e-03 | 1106 | 170 | 15 | EFO_0021796 |
| Disease | Proteinuria | 1.96e-03 | 43 | 170 | 3 | C0033687 | |
| Disease | FEV/FEC ratio | AKAP6 ABHD17A SPEG U2SURP TRPS1 NSD1 ITGA8 ZC3H11B ADAMTS5 NEB ADCY3 JMJD1C ZNF106 CADPS SYNE2 HSPA4 | 2.04e-03 | 1228 | 170 | 16 | EFO_0004713 |
| Disease | prostate carcinoma | ABHD17A BCLAF1 SIDT1 NSD1 EMSY DDX10 RIF1 IGF1R SYNE2 PCDH15 PKHD1 KLKB1 TOR1AIP1 | 2.04e-03 | 891 | 170 | 13 | EFO_0001663 |
| Disease | dementia (is_implicated_in) | 2.10e-03 | 12 | 170 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | urate measurement | DNAH3 PODXL U2SURP NSD1 EPB41L3 RNF115 JMJD1C SLC4A1 NEO1 IGF1R AK5 PKHD1 FBXO34 | 2.12e-03 | 895 | 170 | 13 | EFO_0004531 |
| Disease | S-warfarin to R-warfarin ratio measurement | 2.25e-03 | 95 | 170 | 4 | EFO_0803331 | |
| Disease | birth weight | 2.29e-03 | 399 | 170 | 8 | EFO_0004344 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 2.47e-03 | 13 | 170 | 2 | C0369183 | |
| Disease | Respiratory Depression | 2.47e-03 | 13 | 170 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 2.47e-03 | 13 | 170 | 2 | C0035229 | |
| Disease | Respiratory Failure | 2.47e-03 | 13 | 170 | 2 | C1145670 | |
| Disease | illegal drug consumption | 2.47e-03 | 13 | 170 | 2 | EFO_0005431 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 2.47e-03 | 13 | 170 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4 | 2.47e-03 | 13 | 170 | 2 | cv:C4082197 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 2.47e-03 | 13 | 170 | 2 | C1261502 | |
| Disease | lifestyle measurement | 2.48e-03 | 235 | 170 | 6 | EFO_0010724 | |
| Disease | Kidney Failure, Chronic | 2.69e-03 | 48 | 170 | 3 | C0022661 | |
| Disease | obesity | 2.81e-03 | 241 | 170 | 6 | EFO_0001073 | |
| Disease | refractive error | 2.92e-03 | 326 | 170 | 7 | MONDO_0004892 | |
| Disease | Hypermetropia | 3.02e-03 | 103 | 170 | 4 | HP_0000540 | |
| Disease | retinal vasculature measurement | SEPTIN9 SEPTIN8 ZNF106 FRY XIRP2 TMEM132D SCN7A RASGEF1B PLCE1 | 3.19e-03 | 517 | 170 | 9 | EFO_0010554 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 3.24e-03 | 105 | 170 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | osteoarthritis (implicated_via_orthology) | 3.30e-03 | 15 | 170 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 3.71e-03 | 255 | 170 | 6 | EFO_0009924 | |
| Disease | DiGeorge Syndrome | 3.76e-03 | 16 | 170 | 2 | C0012236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 3.76e-03 | 16 | 170 | 2 | C0795907 | |
| Disease | Diabetic Angiopathies | 3.76e-03 | 16 | 170 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 3.76e-03 | 16 | 170 | 2 | C0025945 | |
| Disease | Blood Coagulation Disorders | 3.76e-03 | 16 | 170 | 2 | C0005779 | |
| Disease | fourth ventricle volume measurement | 3.76e-03 | 16 | 170 | 2 | EFO_0010303 | |
| Disease | Shprintzen syndrome | 3.76e-03 | 16 | 170 | 2 | C0220704 | |
| Disease | Hepatomegaly | 3.76e-03 | 54 | 170 | 3 | C0019209 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.06e-03 | 181 | 170 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Autistic Disorder | 4.15e-03 | 261 | 170 | 6 | C0004352 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 4.24e-03 | 17 | 170 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | body surface area | TENT4A TRPS1 NSD1 ZC3H11B MFAP3 IGF2BP3 IGF1R ITSN2 PKHD1 POLD3 | 4.26e-03 | 643 | 170 | 10 | EFO_0022196 |
| Disease | Neoplasm Invasiveness | 4.35e-03 | 184 | 170 | 5 | C0027626 | |
| Disease | total blood protein measurement | 4.66e-03 | 449 | 170 | 8 | EFO_0004536 | |
| Disease | corneal resistance factor | 4.78e-03 | 451 | 170 | 8 | EFO_0010067 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.82e-03 | 59 | 170 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | Hypermetropia, Myopia | 4.87e-03 | 189 | 170 | 5 | HP_0000540, HP_0000545 | |
| Disease | Hypertensive disease | 4.98e-03 | 190 | 170 | 5 | C0020538 | |
| Disease | birth weight, parental genotype effect measurement | 5.20e-03 | 192 | 170 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | cortical thickness | AKAP6 MYCBP2 EXD1 TM7SF3 TRPS1 SIDT1 BEND3 JMJD1C ZNF106 NEO1 IGF1R CADPS PKHD1 PLCE1 | 5.23e-03 | 1113 | 170 | 14 | EFO_0004840 |
| Disease | Congenital hernia of foramen of Morgagni | 5.29e-03 | 19 | 170 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 5.29e-03 | 19 | 170 | 2 | C0265700 | |
| Disease | refractive error, age at onset, Myopia | 5.32e-03 | 193 | 170 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | serum urea measurement | 5.55e-03 | 195 | 170 | 5 | EFO_0009795 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLTIVEASVNPISKL | 116 | Q96RT1 | |
| ITIIEVPDSSILKKV | 71 | Q6NSW5 | |
| PVITSSKEEQKLIAT | 141 | Q9H3F6 | |
| TVPDEIIDQKQKSTI | 236 | O75366 | |
| TKKVPQVSTPTLVEV | 436 | P02768 | |
| TTVILEVQSNPKIRK | 581 | Q9UKF6 | |
| ESQITTLIVSKPERK | 681 | P02730 | |
| TVIVADDSQKPLEIK | 351 | Q8NHY0 | |
| TVINSKIIVVTIRPE | 781 | O60242 | |
| TKEILIVQILATDPT | 826 | Q9UNA0 | |
| KIPVLVQSKDDVIVT | 336 | O00178 | |
| ISITVSKVDKDQPSI | 456 | Q9NWN3 | |
| PKELSTVQESFLVKI | 226 | A8K2U0 | |
| LLPSNETEKTKITIV | 81 | Q8IZP9 | |
| VTKIAKSVIAPLADQ | 96 | A6NHX0 | |
| NIEKVSKITSPVLII | 236 | Q96GS6 | |
| AETVIQTVKEVLKQP | 1871 | Q5JWR5 | |
| TKSILPITNIKEQIE | 731 | Q5W041 | |
| RATEDVLVKISIKPT | 246 | O94985 | |
| TQPVVTKETAISKLE | 2446 | P11532 | |
| ASPEAKKVAIVTVSQ | 196 | Q96K78 | |
| ATKVALKVVTPIIIS | 981 | O95622 | |
| EVPILKTSNKEISSI | 1481 | Q9Y4F5 | |
| TTNPVILIVDKVLET | 111 | Q99674 | |
| VKAEEKSPISINVKT | 346 | Q9UK58 | |
| TLSVQDAPTKKEFVI | 491 | Q8WYQ5 | |
| IVKLVEEAQTSKAPI | 916 | Q04656 | |
| KVELDPAKVAVLTTV | 121 | A0A1B0GUU1 | |
| PEKVLSAVVQTLVAK | 2421 | Q96L73 | |
| TIKTLSVPVKEDAQL | 351 | Q9Y5H5 | |
| IDKAVVVSPSSLVKN | 211 | Q92698 | |
| STLKRPQVETKIDVS | 21 | Q14699 | |
| LDTIAKVTNKKPITV | 841 | O95980 | |
| TEIPVAKIRTEQESK | 1651 | Q9NZM3 | |
| IRETQSEKKVSPTEI | 1141 | Q14207 | |
| SLEVSRIKKQVSPTE | 221 | Q5T5X7 | |
| EDSVKVLDKATVPII | 206 | Q8NDF8 | |
| VLDKATVPIIKLTDS | 211 | Q8NDF8 | |
| TVPIIKLTDSFTEVK | 216 | Q8NDF8 | |
| EVPIATTAKLVNKVI | 1351 | Q9H2M9 | |
| VTPVPQEEVKTVIRK | 826 | Q9ULU8 | |
| QTVVVKEITIHTKLP | 406 | O00592 | |
| PKTIKTLEENLGITI | 971 | O00370 | |
| ISVTKITKPDGIVEE | 211 | O00165 | |
| RIQVVKKTTTPEGEV | 226 | Q15842 | |
| KVKTSTVDLPIENQL | 571 | P34932 | |
| KQPISVKVISVDELN | 231 | Q92823 | |
| ELAPQETTITEIKQK | 191 | Q9Y6K8 | |
| KVITTVLKFPDDQTQ | 2196 | Q13439 | |
| IIKLKEIFETPTEIS | 101 | Q16566 | |
| VIPAKVVREVLKTTT | 711 | P04035 | |
| VILTLNSTLVDPIVK | 41 | A6NEK1 | |
| PEVISNIKETLKIVS | 16 | A1A4Y4 | |
| LQESIDVAPFTTKIK | 1026 | Q15652 | |
| IRTVLQPKKLVTETA | 331 | Q8NHP7 | |
| VVKDEPETRVAIKTV | 1021 | P08069 | |
| DVIDLRTVPKVEVKT | 2726 | Q9Y6V0 | |
| SHIAEVKTVKVPLVQ | 336 | Q8IYA7 | |
| QTEVPSLVVKKEETV | 641 | Q14149 | |
| KDPVNTKIALITVSD | 376 | Q9HC56 | |
| AISSVEPKVIVKEVK | 1126 | Q92817 | |
| LKTISVEVIPVNDEK | 1261 | Q5H8C1 | |
| VSIISQPQKTIKVAE | 1971 | Q5H8C1 | |
| AVPIQKVQDDTKTLI | 21 | P41159 | |
| AKQKSTVLTIPEIII | 621 | P00488 | |
| TSHVKKTTPELEIVL | 841 | O95163 | |
| KKAAEITVQPTVEEA | 1121 | Q9BZA7 | |
| QTVLSSVKIKLLPDE | 356 | Q495T6 | |
| TVLKTKPQSIQRDII | 186 | Q0VAM2 | |
| VQVEVAEKVQKSSAP | 716 | Q3BBV0 | |
| KIEQDTDTKITISPL | 301 | O00425 | |
| AKLPEGSIVIKTSVI | 986 | P53708 | |
| IPIITSAKTLELAKV | 206 | P55082 | |
| SNVKDVSVPVAEIKI | 236 | Q6VY07 | |
| TVPIIKLTDQETEVK | 316 | Q5XG87 | |
| ALTKEKRISVQTPVD | 961 | O95248 | |
| PLQDVVTTEKEKVTL | 2171 | Q5VST9 | |
| ILEIRTPEAVTSIKK | 1351 | Q96QU1 | |
| KETVRKVTPNTVLEN | 71 | Q8IU89 | |
| SVVLITKPTTVKEAQ | 226 | Q9Y426 | |
| KKITPVPEITVIQTI | 2311 | Q9UFH2 | |
| KVSEVPANTKELVSL | 711 | Q8TD57 | |
| VVLPTKELAQQVSKV | 286 | Q8N8A6 | |
| DVQTSQITKIPILKD | 116 | Q5T6F0 | |
| PDVIAKNRIKETDTI | 651 | Q7Z7M9 | |
| ERITVKKETQSPEQV | 486 | Q9NYF8 | |
| VIIPIKKLSNAIITS | 941 | Q6ZUT9 | |
| KEVTQIKDRSLPAVV | 326 | Q68CZ6 | |
| LIIASKPEVKKTATQ | 491 | O60266 | |
| QKTVLEIDTPKVEQV | 1796 | P20908 | |
| VFEQKAEITLVATKP | 586 | Q9UBF2 | |
| PNIVKLFEVIETEKT | 116 | Q96L34 | |
| KVDLETVPKVSIVAS | 371 | Q8IWC1 | |
| VEDSLATVKVVLIPV | 126 | Q8NA54 | |
| VITKVVTHPFKTIEL | 296 | P04839 | |
| ISEIAAVSKRPEKVI | 481 | P40939 | |
| DITKDTPFSQIKEII | 456 | P03952 | |
| TVTTERPVQVKVVKV | 41 | Q9NV70 | |
| PTIQIKQESGVKIIT | 446 | Q7Z589 | |
| TKELVRSQADKVIEP | 521 | Q13206 | |
| SVVPVKQFNVEVLKT | 2256 | Q5TBA9 | |
| VTKPTVIISQEGDKV | 36 | O15540 | |
| ITTIEVPDSSILKKV | 71 | Q8TCE6 | |
| SVDIPLDKTVVNKDV | 86 | P61353 | |
| KSVVSTPVDLEVKLR | 366 | Q12770 | |
| QVAVKLSLKPTLTEE | 116 | P19022 | |
| QTNLITTVTPEKKAE | 461 | Q9Y2J2 | |
| VKLEISTKEVPVVHT | 966 | Q9Y2J2 | |
| VTLVISQPKEKISKV | 1171 | Q12923 | |
| IPLNTKIALITVTDK | 406 | Q9BZA8 | |
| SSIRSVQETVLPIKK | 291 | P51608 | |
| TPVKKLAQIGTTVVT | 176 | Q92750 | |
| TPSRKQEIIKTTEQL | 531 | Q13554 | |
| TIKTPEITVSIIKEL | 386 | Q8TED0 | |
| FITKINPETLETIKQ | 151 | Q16518 | |
| KEKITSLPTVTVTQE | 206 | Q9Y4L5 | |
| EDKTLESAVVKVINP | 116 | Q8WUY3 | |
| KVVPKTVENFVALAT | 61 | P45877 | |
| PVLEVKLSNLEVKTS | 376 | Q9P0V3 | |
| ERLKTLQKPESVISV | 5191 | Q8WXH0 | |
| AILTGKTVAVPVKVV | 441 | Q14C87 | |
| AILTSVIVTPLDVVK | 26 | Q8TBP6 | |
| AEKKVVKITSEIPQT | 86 | P82979 | |
| LSEIQALTLTKEKVP | 161 | Q7L592 | |
| PETKVILKTENTREI | 481 | Q96DL1 | |
| VESIEEVSKIIKRAP | 261 | O60502 | |
| LTTKIPFKEVVEAID | 1456 | Q9P212 | |
| VNKTIDEPIFKISEI | 46 | Q9H0K6 | |
| PVVVSKISKEQRAEL | 81 | Q9NSN8 | |
| LKSLESIVKSEVFPV | 531 | Q5UIP0 | |
| LFPVLIDTKSVTKDI | 286 | Q8NA58 | |
| RKAVIQLTTKTQPVE | 11 | Q8IV36 | |
| VTVVSKEGKPKTIIV | 961 | Q92859 | |
| KEIINASKAISTPII | 1071 | O14802 | |
| IPKTIEIKSITHDIE | 336 | Q9UHD8 | |
| VVNIVPVIAKADTLT | 436 | Q9UHD8 | |
| STPTQISEIIIKLIK | 4166 | O75592 | |
| TPNQPITVKITEIRK | 1896 | P08F94 | |
| VSPSDKVLIQEKTQL | 1046 | P41252 | |
| KVVETVKQNPIEVTS | 446 | Q15714 | |
| AVKEEKIVEQPTVSV | 256 | Q15054 | |
| NVEEVTLPKTVNTKK | 351 | Q8TAQ2 | |
| TLSQAIVKVVIPTER | 411 | O15042 | |
| NIDKISKITSPVLII | 216 | Q5VST6 | |
| VAAPTSLTQIKEKVL | 2081 | Q13023 | |
| DTVILDKSKITVPFL | 216 | Q8TBZ0 | |
| TTLAKDTPLEEVVKV | 556 | P51800 | |
| KEKRVTVQLPTESIQ | 2601 | A4UGR9 | |
| QVVLTPKASTVVKGV | 246 | Q63HM9 | |
| PLNVVKTEKVDRSTQ | 1196 | Q9UHF7 | |
| SVVIKTVIALTPELK | 481 | Q8NHH1 | |
| VKSLTLKVSPVIINT | 1646 | Q96RL7 | |
| TISKKTVRSIQEAPV | 171 | Q5JTV8 | |
| TVIKEVLKRATVAPE | 36 | Q9BWD1 | |
| RSVTLESKKQLIEPV | 246 | P82933 | |
| KVTVQSLSPAKEVVS | 2926 | Q15772 | |
| TQDPVVKVSEIVAKS | 761 | O95757 | |
| KNLEVTIVPSIKESV | 291 | Q9NXL6 | |
| KAESTAVQLKIPEVE | 1086 | Q9BXM0 | |
| LKTKADATAQIEVIP | 6 | Q92753 | |
| DSKVNIIPIIAKADT | 176 | Q92599 | |
| IIPIIAKADTISKSE | 181 | Q92599 | |
| TELRVQKLSVSKPTV | 131 | Q9Y279 | |
| VNIIPVIAKADTVSK | 201 | Q9P0V9 | |
| VKTLTGKTITLEVEP | 81 | P0CG47 | |
| KTILEEEITPTIQKL | 196 | O95347 | |
| INLISPDTKSVVLEK | 366 | O60343 | |
| EAKPTVNVKQSVVKV | 646 | A0A1B0GTU1 | |
| ITVTKLVTVTKPVPV | 276 | Q96KM6 | |
| AIPITELTKSQVQDK | 241 | P17098 | |
| ITCEPITTTLKRKQE | 1611 | Q01118 | |
| SLKIQLETKEPVTSE | 731 | Q5QJ38 | |
| VKTLTGKTITLEVEP | 81 | P0CG48 | |
| VKTLTGKTITLEVEP | 461 | P0CG48 | |
| KFNTTSVIKIAVEPV | 581 | Q15029 | |
| VTVYTTKIITKVVEP | 666 | Q15063 | |
| KKIEEVSNTPLLLTV | 1011 | Q8IWB9 | |
| DTEQDVLTVKPVRKV | 1371 | Q9H2Y7 | |
| IPENSEIKTSIEVKA | 861 | Q14966 | |
| EDSPQTVIIEKVVKQ | 96 | Q2M3W8 | |
| TLSENKEEPVKLAVV | 276 | Q15061 | |
| VPQVKASALKVVTLT | 221 | Q9NS93 | |
| PETTAKTIVLVKNVL | 1471 | P35573 | |
| SKGKITVVQDTPEIL | 6126 | P20929 |